March 2026

Alto Neuroscience, a clinical-stage biopharmaceutical company focused on neuropsychiatric disorders, has secured $120 million from institutional and accredited investors to advance ALTO-207, a fixed-dose combination targeting treatment-resistant depression. ALTO-207 is a novel therapy for treatment-resistant depression that pairs pramipexole, a dopamine receptor agonist, with ondansetron. The combination is designed to enhance antidepressant effects in patients…

Ethereum price has finally begun to recover, climbing back above the psychologically significant $2,150 zone after weeks of testing holders’ patience. As usual, the requirements are the same: ETH must close the daily candle above $2,200 and hold this level to potentially build a further upward leg (with $2,500-2,700 as immediate targets). However, breaking below…

President Donald Trump’s family-backed crypto project, World Liberty Financial (WLFI) has passed a governance proposal requiring token holders to lock up their tokens for nearly six months in order to participate in protocol voting. Summary WLFI holders approved a governance proposal requiring token holders to stake their tokens for 180 days in order to participate…

Tesla has received regulatory clearance to convert its investment in Elon Musk’s artificial intelligence firm xAI into a small stake in SpaceX, formalizing financial ties between the billionaire’s companies ahead of the rocket maker’s planned initial public offering, according to a Bloomberg report. Filings with the US Federal Trade Commission list Tesla as the acquirer…